Avita Medical | 1811094D - Sales Revenues

Stock Price
1.09
Daily Change
-0.05 -3.96%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.19

Avita Medical reported AUD18.42M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Celltrion KRW 1.03T 68.49B Sep/2025
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 27.15B 3.05B Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Mayne Pharma AUD 195.04M 20.71M Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
Polynovo AUD 34.58M 24.94M Jun/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025
Tilray USD 217.51M 74.75M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025